You searched for "PDR"
The increased use of surgical adjuncts in complex cataract surgeries undertaken in the COVID-19 pandemic
The authors explore whether more complicated cataract operations have been performed in the NHS since the start of the coronavirus pandemic. Restrictions in availability of access to elective cataract surgery during the COVID-19 pandemic and subsequent case prioritisation based on...Presentation feedback tools
4 October 2023
| David Haider
|
EYE - General
The topic of this issue stems from a desire to find the best free-to-use tool for collecting feedback after a presentation. It is a common requirement for clinicians to collect audience feedback after a teaching session. This feedback contributes toward...
Ocular mucous membrane pemphigoid: the importance of early detection and treatment
1 August 2014
| Inderpaul S Sian, Bhaskar Gupta, David Cadman, Keith Bates
|
EYE - Oculoplastic, EYE - Orbit
Mucous membrane pemphigoid (MMP) is an autoimmune blistering disorder that is characterised by subepithelial bullae. The ocular manifestation of MMP, ocular mucous membrane pemphigoid (OMMP), is a sight-threatening condition characterised by conjunctival cicatricial changes associated with corneal vascularisation and scarring....
Cataract incidence rates in patients from the UK suffering with diabetes mellitus
1 October 2018
| Rupert Bourne (Prof), Clare Bailey
|
EYE - Cataract, EYE - Refractive, EYE - General
The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...
Towards virtual reality conferences?
5 August 2020
| George Liu, Mehran Zarei-Ghanavati, Rawya A Diab, Mohamed Bahga Goweida, Hasan Naveed, Christopher Liu (Prof)
|
EYE - General
COVID-19 is forcing us to reconsider every aspect of life. The authors ask what future ophthalmic meetings could look like. The coronavirus disease COVID-19 pandemic disrupted ophthalmic conferences resulting in the cancellation of the majority of meetings in 2020, e.g....
There will be a 27% rise in the number of people living with sight loss in the UK by 2035, RNIB the UK’s leading sight loss charity predicts
20 October 2024
|
charity, international, government, call to action, UK, local, sight loss, statistics
This World Sight Day, leading sight loss charity the Royal National Institute of Blind People (RNIB) was calling for the UK Government to prioritise eye health. This is after fresh insight from the charity that shows there will be a...
Effect of selenium and vitamin E supplements on the development and progression of cataracts
The Selenium and Vitamin E Cancer Prevention Trial (SELECT) investigated the influence of dietary supplements on the development of prostate cancer in a group of 35,533 middle aged and older, apparently healthy men. The SELECT Eye Endpoint (SEE) study is...What's trending Dec/Jan 2021
7 December 2020
| David Ellis
|
EYE - General, EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #threeblindmice US company Nanoscope Therapeutics has developed a new treatment which is hoped will restore vision in those affected by retinal...
Birdshot chorioretinopathy: an important differential
1 April 2015
| Zaria Ali, Mohammed Alarbi, Salwa Abugreen
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Birdshot chorioretinopathy (BSCR) is a relatively uncommon cause of posterior uveitis which often has a relapsing and remitting course [1,2]. We present a case which demonstrates how remission can be obtained for several years using cyclosporine. Case report A 44-year-old...
Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies
1 October 2018
| Rod McNeil
|
EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
Update on emerging therapies for age-related macular degeneration
4 December 2023
| Rod McNeil
|
EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...
